Director Kare Schultz filed a Form 4 with the SEC on August 14, 2026, disclosing the acquisition of 8,223 Restricted Stock Units in Hims & Hers Health, Inc. (NASDAQ:HIMS) with a transaction date of August 12, 2026.

Key Highlights

  • Reporting Person: Kare Schultz, listed as a Director of Hims & Hers Health, Inc.
  • Security Granted: 8,223 Restricted Stock Units (RSUs) in Class A Common Stock, acquired on August 12, 2026.
  • Price: The RSUs were acquired at $0 per unit, according to the filing.
  • Post-Transaction Holdings: Schultz beneficially owns 8,223 derivative securities following the reported transaction, held directly.
  • Vesting Condition: The RSUs vest in full on the first Company quarterly vesting date after the earlier of the next annual stockholder meeting or the first anniversary of the grant date, subject to continuous service.

Kare Schultz RSU Award Details at Hims & Hers Health

According to the filing, Kare Schultz, a Director of Hims & Hers Health, Inc. (NASDAQ:HIMS), received a grant of 8,223 Restricted Stock Units on August 12, 2026. The filing notes that each RSU "represent[s] a contingent right to receive one share of Class A Common Stock for each RSU." The acquisition was recorded under transaction code "A" (acquired) and the price of the derivative security is listed as $0.

The filing discloses that the RSUs are "subject to continuous service" and will vest in full on the first Company quarterly vesting date occurring after the earlier of: the date of the Company's next annual stockholder meeting, or the first anniversary of the grant date of the award. Following the reported transaction, Schultz beneficially owns 8,223 RSUs directly, with no previously reported holdings in Table II indicated in the filing.

The Form 4 was signed by Kimberly Mather as Attorney-in-Fact for Kare Schultz and was dated August 14, 2026. No non-derivative securities were reported in Table I of the filing, and no 10b5-1 plan box was checked in connection with this transaction.

What Was Disclosed

The filing reported the grant of 8,223 RSUs to Hims & Hers Health Director Kare Schultz on August 12, 2026, at $0 cost, each convertible into one share of Class A Common Stock upon vesting, subject to continuous service conditions.